SVCM

Saturn V Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 177.94%
This Quarter Est. Return
1 Year Est. Return
+177.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$247M
AUM Growth
+$48.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$22M
2
+$13.9M
3
+$10.1M
4
LENZ
LENZ Therapeutics
LENZ
+$10M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.31M

Top Sells

1
+$27.8M
2
+$6.46M
3
+$5.2M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$5.06M
5
SLN
Silence Therapeutics
SLN
+$4.05M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
1
Jazz Pharmaceuticals
JAZZ
$8.57B
$22M 8.9%
+206,952
IRON icon
2
Disc Medicine
IRON
$3.4B
$21M 8.5%
396,115
-122,062
AMLX icon
3
Amylyx Pharmaceuticals
AMLX
$1.39B
$20.9M 8.47%
3,260,570
+834,134
PCVX icon
4
Vaxcyte
PCVX
$6.37B
$17.7M 7.17%
544,221
+311,926
COGT icon
5
Cogent Biosciences
COGT
$5.15B
$16.5M 6.69%
2,297,524
+817,504
CELC icon
6
Celcuity
CELC
$3.93B
$15.8M 6.41%
1,185,520
+91,843
CGON icon
7
CG Oncology
CGON
$3.13B
$15.3M 6.18%
586,647
+8,951
XENE icon
8
Xenon Pharmaceuticals
XENE
$3.15B
$14.7M 5.94%
468,364
+54,653
DYN icon
9
Dyne Therapeutics
DYN
$2.68B
$13.9M 5.62%
+1,455,429
MLTX icon
10
MoonLake Immunotherapeutics
MLTX
$905M
$13.7M 5.56%
290,784
-53,065
MRUS icon
11
Merus
MRUS
$7.28B
$11.8M 4.78%
224,260
-98,951
CNTA
12
Centessa Pharmaceuticals
CNTA
$3.71B
$10.4M 4.22%
793,327
+344,635
LENZ
13
LENZ Therapeutics
LENZ
$801M
$10M 4.07%
+342,312
NBIX icon
14
Neurocrine Biosciences
NBIX
$14.4B
$7.31M 2.96%
+58,181
OCUL icon
15
Ocular Therapeutix
OCUL
$2.41B
$6.76M 2.74%
728,576
+130,385
ASND icon
16
Ascendis Pharma
ASND
$12.5B
$6.59M 2.67%
38,191
-161,073
ARGX icon
17
argenx
ARGX
$55.9B
$5.67M 2.3%
10,285
-3,577
ABVX
18
Abivax
ABVX
$8.59B
$4.76M 1.93%
622,479
+69,553
SNDX icon
19
Syndax Pharmaceuticals
SNDX
$1.44B
$4.69M 1.9%
500,551
-540,729
NAMS icon
20
NewAmsterdam Pharma
NAMS
$4.35B
$4M 1.62%
220,695
+104,342
CTNM
21
Contineum Therapeutics
CTNM
$311M
$1.27M 0.51%
319,348
-241,631
REPL icon
22
Replimune Group
REPL
$705M
$1.2M 0.49%
+128,917
KALV icon
23
KalVista Pharmaceuticals
KALV
$688M
$710K 0.29%
62,793
-192,267
SLN
24
Silence Therapeutics
SLN
$323M
$201K 0.08%
34,737
-697,726
CRNX icon
25
Crinetics Pharmaceuticals
CRNX
$4.05B
– –
-59,017
1
2